Best Practice Case Studies-Dermatology

Pdf Summary

This document provides answers and explanations to study questions related to medical cases in sports health contexts, particularly concerning infections like herpes gladiatorum and mononucleosis among athletes.

<strong>Question 1</strong> deals with the treatment of herpes gladiatorum. If an athlete is diagnosed clinically with this condition, the correct treatment is Valacyclovir 1g by mouth twice daily for 7 to 14 days. This dosage is suitable for treating primary infections in adults, distinguishing it from other dosages which address recurrent infections or different age groups.

<strong>Question 2</strong> focuses on NCAA guidelines regarding wrestlers with herpes simplex lesions. The guidelines specify that a wrestler may participate in competitions if all lesions are crusted over, they are asymptomatic for viral infection, have had no new blisters for at least 72 hours, and have been on antiviral therapy for at least 120 hours. The answer indicates that all lesions must be dried with a firm adherent crust, and no lesions should be covered during the competition.

<strong>Question 3</strong> addresses a case involving suspected mononucleosis in a female basketball player. Here, the most sensitive test for diagnosis and deciding on the athlete's participation in a game is the viral capsid antigen IgM test. This test has a 97% sensitivity and is more reliable than other tests like the heterophile antibody test, particularly within the first weeks of symptom onset.

Each question and answer is supported by references to relevant medical literature, highlighting treatment protocols, NCAA guidelines, and diagnostic tests for infectious conditions commonly encountered in sports medicine.

Meta Tag

Edition 3rd Edition

Related Case 3rd Edition, CASE 11

Topic Dermatology

Keywords

herpes gladiatorum

mononucleosis

Valacyclovir

NCAA guidelines

wrestlers

viral capsid antigen IgM

sports health

antiviral therapy

infections

athletes

3rd Edition

3rd Edition, CASE 11

Dermatology